Problems most concerning to parents of children with ADHD and emotional dysregulation in a randomized controlled trial of multinutrients: MADDY secondary …

G Tost, P Srikanth, A Bruton, IE Hatsu… - European Child & …, 2024 - Springer
G Tost, P Srikanth, A Bruton, IE Hatsu, BMY Leung, HK Ast, LP Eiterman, LM Robinette
European Child & Adolescent Psychiatry, 2024Springer
Objective With dual focus on structured, objective quantification of parent observations of
child's behavior and identifying behaviors most amenable to change, this report examines
Parent Target Problems (PTP) as a secondary outcome in a randomized clinical trial (RCT)
of children with attention-deficit/hyperactivity disorder (ADHD) in which one primary
outcome, Clinical Global Impression-Improvement, showed a significant advantage of
multinutrients over placebo and the other, Likert-type parent ratings, showed significant …
Abstract
Objective
With dual focus on structured, objective quantification of parent observations of child’s behavior and identifying behaviors most amenable to change, this report examines Parent Target Problems (PTP) as a secondary outcome in a randomized clinical trial (RCT) of children with attention-deficit/hyperactivity disorder (ADHD) in which one primary outcome, Clinical Global Impression-Improvement, showed a significant advantage of multinutrients over placebo and the other, Likert-type parent ratings, showed significant improvement in both groups, without significant difference between them.
Method
In a multisite 8-week RCT of broad-spectrum micronutrients (“multinutrients”), parents of children ages 6–12 (N= 126, 73% male, 88% white) with ADHD and emotional dysregulation nominated their child’s most concerning problem (s) at baseline and quantified them by frequency, duration, impairment, and consequences. At subsequent visits, parents re-quantified the problem (s). Blinded child psychiatrists independently reviewed the PTPs and rated change at two timepoints compared to baseline. PTPs were grouped into 9 categories. Mean ratings were compared between active and placebo groups and explored by category.
Results
By week 8, a significant separation favored multinutrients: 38% of the multinutrient group were “definitely improved” or better, compared to 25% of the placebo group, and ratings of “no change” or “worse” occurred in 35% with placebo versus 23% with multinutrients (p= 0.04). Inattention (72.2%) and emotional dysregulation (69.1%) were the most frequently reported PTP categories. Inattention and internalizing symptoms improved more with multinutrients than placebo (p= 0.01, d= 0.55; p= 0.03, d= 0.80, respectively). The multinutrient advantage was not significant for 7 other symptoms, including hyperactivity/impulsivity, aggression, autistic symptoms, or emotional dysregulation/irritable oppositionality.
Conclusions
This secondary analysis found that the multinutrients, compared to placebo, were associated with improvements in parental concerns overall, and in two domains specifically: inattention and internalizing symptoms (anxiety/depression), but not in seven domains: hyperactivity/impulsivity, aggression, autistic symptoms or physiological symptoms, peer relationships or emotional dysregulation/irritable oppositionality.
Springer
以上显示的是最相近的搜索结果。 查看全部搜索结果

Google学术搜索按钮

example.edu/paper.pdf
搜索
获取 PDF 文件
引用
References